- Drug Pipelines
- April 2025
- 400 Pages
Global
From €4464EUR$5,000USD£3,905GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1785EUR$2,000USD£1,562GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €4464EUR$5,000USD£3,905GBP
- Report
- May 2025
- 114 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- December 2024
- 200 Pages
Global
From €3348EUR$3,750USD£2,929GBP
- Report
- May 2022
- 467 Pages
Global
From €4284EUR$4,799USD£3,748GBP
- Report
- May 2020
- 275 Pages
Global
From €4374EUR$4,899USD£3,826GBP
- Report
- April 2022
- 121 Pages
Global
From €1695EUR$1,899USD£1,483GBP
- Report
- January 2022
- 310 Pages
Global
From €4284EUR$4,799USD£3,748GBP
- Report
- April 2018
- 449 Pages
Global
From €3124EUR$3,499USD£2,733GBP
- Report
- May 2024
- 340 Pages
Global
From €5146EUR$5,966USD£4,350GBP
- Report
- January 2022
- 109 Pages
Global
From €2678EUR$3,000USD£2,343GBP
- Report
- October 2019
Global
From €2250EUR$2,520USD£1,968GBP
€2500EUR$2,800USD£2,187GBP
- Report
- February 2024
- 379 Pages
Global
From €4419EUR$4,950USD£3,866GBP
- Report
- December 2021
- 353 Pages
Global
From €4910EUR$5,500USD£4,296GBP
- Report
- May 2023
- 240 Pages
Global
From €2455EUR$2,750USD£2,148GBP
€4910EUR$5,500USD£4,296GBP
- Report
- May 2024
- 129 Pages
Global
From €5802EUR$6,499USD£5,076GBP
- Report
- December 2021
- 100 Pages
Global
From €5312EUR$5,950USD£4,647GBP
- Report
- May 2024
- 290 Pages
Global
From €4464EUR$5,000USD£3,905GBP
- Report
- May 2024
- 182 Pages
Global
From €4017EUR$4,500USD£3,515GBP

Transgenics is a field of genomics that focuses on the transfer of genetic material from one organism to another. It is used to create organisms with desired traits, such as disease resistance, increased yield, or improved nutrition. Transgenics is used in a variety of industries, including agriculture, biotechnology, and pharmaceuticals.
Transgenics is a rapidly growing field, with new technologies and techniques being developed to improve the efficiency and accuracy of gene transfer. This has enabled the development of new products and services, such as genetically modified crops, animal models for drug development, and gene therapy.
Companies in the transgenics market include Monsanto, Syngenta, DuPont, and Bayer. Other companies, such as Calyxt, Intrexon, and Cellectis, are also involved in the development of transgenic products and services. Show Less Read more